Clinical impact of pancreatic invasion in T1‐stage distal bile duct cancer and prognostic factors associated with long‐term survival: A multicenter study
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Hepato-Biliary-Pancreatic Sciences"
DOI: 10.1002/jhbp.12042
Abstract: The eighth edition of the AJCC staging system introduced a shift in the staging of distal bile duct cancer (DBC), emphasizing the depth of invasion over adjacent organ invasion. This study aimed to evaluate the… read more here.
Keywords: clinical impact; impact pancreatic; bile duct; distal bile ... See more keywords
The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer
Sign Up to like & getrecommendations! Published in 2021 at "Surgery Today"
DOI: 10.1007/s00595-020-02188-z
Abstract: Purpose The C-reactive protein (CRP)/albumin ratio has been identified as a potential prognostic factor for several malignancies. We, therefore, assessed the prognostic role of the CRP/albumin ratio in resected extrahepatic cholangiocarcinoma (EC). Materials and methods… read more here.
Keywords: bile duct; duct cancer; albumin ratio; crp albumin ... See more keywords
Preoperative Cholangitis Affects Survival Outcome in Patients with Extrahepatic Bile Duct Cancer
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-017-3388-z
Abstract: BackgroundIt remains controversial whether preoperative cholangitis affects long-term outcomes after resection in patients with extrahepatic bile duct cancer.MethodsA total of 107 patients with extrahepatic bile duct cancer who underwent resection with curative intent from 2008… read more here.
Keywords: extrahepatic bile; duct cancer; cholangitis; bile duct ... See more keywords
Involvement of Epigenomic Factors in Bile Duct Cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Seminars in liver disease"
DOI: 10.1055/s-0042-1748188
Abstract: Cholangiocarcinoma (CCA) is the second most common type of primary liver cancer. Due to its often-silent manifestation, sporadic nature, and typically late clinical presentation, it remains difficult to diagnose and lacks effective nonsurgical therapeutic options.… read more here.
Keywords: duct cancer; involvement epigenomic; bile duct; epigenomic factors ... See more keywords
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer
Sign Up to like & getrecommendations! Published in 2024 at "Future Oncology"
DOI: 10.1080/14796694.2024.2364504
Abstract: Summary What is this summary about? This summary describes the results from a phase 2 study called FOENIXCCA2. The study evaluated treatment with futibatinib in people with a rare form of advanced bile duct cancer… read more here.
Keywords: cancer; treatment; duct cancer; language ... See more keywords
Biliary Schwannoma That Required Differentiation from Bile Duct Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Case Reports in Gastroenterology"
DOI: 10.1159/000515369
Abstract: Schwannomas are benign tumors originating from Schwann cells, which are the main component of the neural sheath. Biliary schwannomas are extremely rare. We report the case of a 78-year-old man who presented with no abdominal… read more here.
Keywords: extrahepatic bile; bile; duct cancer; case ... See more keywords
Radiation therapy for extrahepatic bile duct cancer: Current evidences and future perspectives
Sign Up to like & getrecommendations! Published in 2019 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v7.i11.1242
Abstract: Extrahepatic bile duct cancer (EBDC) is a rare malignancy that involves neoplastic changes extending from both hepatic ducts to the common bile duct. The treatment of choice is surgical resection, but the predominant pattern of… read more here.
Keywords: extrahepatic bile; duct cancer; radiotherapy; bile duct ... See more keywords
Targeting AXL Using the AVB-500 Soluble Receptor and through Genetic Knockdown Inhibits Bile Duct Cancer Growth and Metastasis
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15061882
Abstract: Simple Summary Bile duct cancer (cholangiocarcinoma) is a relatively rare cancer type that has a 5-year survival rate of 26% if diagnosed early, but a survival rate of less than 10% if the cancer has… read more here.
Keywords: duct cancer; growth; bile duct; tumor ... See more keywords
Disparities in the Diagnosis and Treatment of Bile Duct Cancer in People with Disabilities: A National Cohort Study in South Korea
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Environmental Research and Public Health"
DOI: 10.3390/ijerph192416625
Abstract: We aimed to evaluate the impacts of disability on the diagnosis, treatment, and prognosis of bile duct cancer (BDC) according to the severity and type of disability. Patients diagnosed with BDC were selected from an… read more here.
Keywords: duct cancer; disabilities national; diagnosis treatment; people disabilities ... See more keywords